Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Nanobiotix S.A. - Sponsored ADR (NBTX) Stock-Based Compensation data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$71.00M |
|
$19.24M |
|
$19.74M |
|
$76.66M |
|
$65.06M |
|
-- |
|
$107.18M |
|
$172.25M |
|
$-95.58M |
|
$-95.59M |
|
$-95.58M |
|
-- |
|
| Cash Flow Statement Financials | |
$-37.81M |
|
$-0.65M |
|
$42.33M |
|
$56.27M |
|
$59.68M |
|
$3.41M |
|
|
Stock-Based Compensation |
-- |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|